Health officials complain that pharmaceutical companies refuse to share samples needed to develop affordable generic versions of brand-name medicines. https://www.nytimes.com/2018/04/14/us/politics/drug-companies-generic.html?smprod=nytcore-ipad&smid=nytcore-ipad-share